Giovanni Rizzo has an extensive experience in Biotech and MedTech. He worked as a director of Biology at Intercept Pharmaceuticals Inc; consultant at Index Ventures (MedicXi), venture capital firm in life science; Vice President of Yaqrit Ltd, spin-off University College London; member of the board of directors and chief of the innovation division of Zcube – Zambon Group. Currently CEO of Biouniversa, biotech developing antibodies for oncological indications. Honorary researcher at University College London (UCL) at the Institute of Gastroenterology and liver disease. Invited teacher at Bicocca University – Milan. Member of the board of directors at IntrepidaBio, biotech of San Diego – California.